Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography

Medical Research Council Cyclotron Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, England.

To assess coronary vasodilator reserve after orthotopic heart transplantation, regional myocardial perfusion was measured with oxygen-15-labeled water and dynamic positron emission tomography in 14 cardiac allograft recipients who were not experiencing rejection and who had no angiographic evidence of epicardial coronary sclerosis 15 to 73 months (mean +/- SD 43 +/- 19) after transplantation (group I). Twelve normal men with an average age of 31 years (group II) served as a control group. Regional perfusion was measured at rest and after the intravenous administration of 0.6 mg/kg body weight of dipyridamole. Rest regional myocardial blood flow was homogeneously distributed throughout the left ventricle and was significantly higher in transplant recipients (mean 1.16 +/- 0.26 ml/g per min [range 0.8 to 1.73] than in normal subjects (mean 0.85 +/- 0.13 ml/g per min [range 0.57 to 0.99]; p = 0.001) as was rest heart rate-systolic blood pressure product (rate-pressure product 11,255 +/- 2,540 vs. 7,073 +/- 1,306; p less than 0.001). After dipyridamole, perfusion in the transplant recipients was homogeneous and slightly lower (2.73 +/- 1.03 vs. 3.40 +/- 1.09 ml/g per min; p = NS), whereas rate-pressure product was slightly higher (12,179 +/- 2,266 vs. 10,885 +/- 1,895; p = NS) than the value in normal subjects. Dipyridamole vasodilator response (dipyridamole/rest myocardial blood flow) ranged from 1.23 to 4.92 (mean 2.50 +/- 1.13) in group I and from 2.65 to 5.45 (3.97 +/- 0.89) in group II (p = 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				G.R Ciliberto, L Ruffini, M Mangiavacchi, M Parolini, R Sara, D Massa, R De Maria, E Gronda, E Vitali, and O Parodi Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation Eur. Heart J., June 1, 2001; 22(11): 964 - 971. [Abstract] [PDF]

				G. Berkenboom, V. Crasset, and P. Unger Coronary endothelial dysfunction in the early months after heart transplantation J. Am. Coll. Cardiol., March 1, 2001; 37(3): 969 - 969. [Full Text] [PDF]

				J. Schwitter, T. DeMarco, S. Kneifel, G. K. von Schulthess, M. C. Jorg, H. Arheden, S. Ruhm, K. Stumpe, A. Buck, W. W. Parmley, et al. Magnetic Resonance-Based Assessment of Global Coronary Flow and Flow Reserve and Its Relation to Left Ventricular Functional Parameters : A Comparison With Positron Emission Tomography Circulation, June 13, 2000; 101(23): 2696 - 2702. [Abstract] [Full Text] [PDF]

				T. L. Wolford, T. J. Donohue, R. G. Bach, J. H. Drury, E. A. Caracciolo, M. J. Kern, and L. W. Miller Heterogeneity of Coronary Flow Reserve in the Examination of Multiple Individual Allograft Coronary Arteries Circulation, February 9, 1999; 99(5): 626 - 632. [Abstract] [Full Text] [PDF]

				K. F. Kofoed, J. Czernin, J. Johnson, J. Kobashigawa, M. E. Phelps, H. Laks, and H. R. Schelbert Effects of Cardiac Allograft Vasculopathy on Myocardial Blood Flow, Vasodilatory Capacity, and Coronary Vasomotion Circulation, February 4, 1997; 95(3): 600 - 606. [Abstract] [Full Text]

				G. Vassalli, A. Gallino, W. Kiowski, Z. Jiang, M. Turina, and O. M. Hess Reduced Coronary Flow Reserve During Exercise in Cardiac Transplant Recipients Circulation, February 4, 1997; 95(3): 607 - 613. [Abstract] [Full Text]